By Judith Wenshuk, peptide research writer
Quick Answer: CJC-1295 and Ipamorelin are two growth-hormone-secretagogue compounds studied together because they work through complementary mechanisms — CJC-1295 extends growth hormone release duration, while Ipamorelin triggers a cleaner pulse of release. Together, they’re one of the most commonly paired combinations in growth-hormone research.
Among growth-hormone-related research peptides, this specific pairing shows up more than almost any other combination, and there’s a real mechanistic reason for that rather than just habit.
How Each Compound Works
CJC-1295 is a GHRH analogue — similar in category to Tesamorelin — that extends the duration of growth hormone release once triggered. Ipamorelin is a ghrelin-receptor agonist that triggers growth hormone release itself, and is generally regarded as one of the “cleaner” compounds in its category because it’s more selective for growth hormone release without significantly affecting cortisol or other hormones the way some older secretagogues do.
Why They’re Paired
The reasoning behind combining them is straightforward: Ipamorelin triggers the release, and CJC-1295 extends how long that release lasts. Used together, research interest centers on whether this produces a more sustained growth hormone signaling profile than either compound would on its own.
CJC-1295: No DAC vs. With DAC
Worth knowing if you’re comparing products: CJC-1295 is available in two forms. “No DAC” has a shorter half-life and is the form typically paired with Ipamorelin for a more defined release pattern. The DAC version has an extended half-life, which changes the dosing frequency and research application. Most CJC/Ipamorelin blends use the No DAC version specifically.
How It Compares to Other Growth-Hormone Compounds
If you’re deciding between this pairing and Tesamorelin specifically, or want the full picture including HGH itself, we’ve written both comparisons.
Frequently Asked Questions
Is CJC-1295/Ipamorelin the same as taking HGH directly? No — both compounds work by stimulating the body’s own growth hormone release rather than supplying growth hormone directly, which is the core difference from HGH itself.
Why does Ipamorelin have a reputation as “cleaner” than other secretagogues? It’s more selective for growth hormone release specifically, with less research-reported impact on cortisol and other hormones compared to some older-generation compounds in the same category.
Is this combination available as a research compound in Canada? Yes — CJC-1295 and Ipamorelin are available individually or as a pre-combined blend through research peptide suppliers in Canada.
Leave a Reply